His primary areas of investigation include Immunology, Hepatitis C virus, Hepatitis C, Virology and Immune system. Many of his research projects under Immunology are closely connected to Immunoglobulin M with Immunoglobulin M, tying the diverse disciplines of science together. Andrew H. Talal combines subjects such as Dendritic cell, Epidemiology and Pathogenesis with his study of Hepatitis C virus.
His studies deal with areas such as Phenotype, Priming and CD8 as well as Pathogenesis. His studies in Hepatitis C integrate themes in fields like Fibrosis, Liver disease, Ribavirin and Pharmacoeconomics. Viral replication and Virus are the core of his Virology study.
Hepatitis C virus, Virology, Immunology, Hepatitis C and Internal medicine are his primary areas of study. As a member of one scientific family, Andrew H. Talal mostly works in the field of Hepatitis C virus, focusing on Substance use and, on occasion, Antigen. As part of his studies on Virology, Andrew H. Talal frequently links adjacent subjects like Drug.
As a part of the same scientific study, Andrew H. Talal usually deals with the Hepatitis C, concentrating on Family medicine and frequently concerns with Psychiatry. His work in Internal medicine covers topics such as Gastroenterology which are related to areas like Fibrosis and Biopsy. His study looks at the intersection of Pathogenesis and topics like Dendritic cell with Priming, Phenotype and CD8.
His primary areas of investigation include Hepatitis C virus, Hepatitis C, Virology, Internal medicine and Telemedicine. He is interested in Hepacivirus, which is a field of Hepatitis C virus. His Hepatitis C research is multidisciplinary, incorporating elements of Opiate Substitution Treatment, Opioid Agonist, Pharmacology and Family medicine.
His work deals with themes such as Immunology and Drug, which intersect with Virology. His study in Immunology is interdisciplinary in nature, drawing from both Regulation of gene expression and Peripheral blood mononuclear cell. In his work, Ombitasvir, Liver biopsy, Dasabuvir and Paritaprevir is strongly intertwined with Gastroenterology, which is a subfield of Internal medicine.
His primary areas of study are Hepatitis C virus, Hepatitis C, Psychiatry, Internal medicine and Chromatography. His research in Hepatitis C virus intersects with topics in Interferon, Opioid Agonist, Family medicine and Hepatitis. Within the field of Virology and Immunology Andrew H. Talal studies Hepatitis C.
The various areas that Andrew H. Talal examines in his Virology study include Hepatocellular carcinoma, Antigen and Substance use. His work on Serology and Hepacivirus as part of general Immunology research is often related to Context and Identification, thus linking different fields of science. His research investigates the connection between Internal medicine and topics such as Gastroenterology that intersect with issues in Biopsy, Genotype, Liver biopsy, Pharmacology and Excretion.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.
Linqi Zhang;B. Ramratnam;K. Tenner-Racz;Yuxian He.
The New England Journal of Medicine (1999)
Neutralizing antibody response during acute and chronic hepatitis C virus infection
Carine Logvinoff;M E Major;D Oldach;S Heyward.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Hepatitis C virus infection in USA: an estimate of true prevalence
Eric W Chak;Andrew H. Talal;Kenneth E. Sherman;Eugene R. Schiff.
Liver International (2011)
NATURALLY OCCURRING DOMINANT RESISTANCE MUTATIONS TO HEPATITIS C VIRUS PROTEASE AND POLYMERASE INHIBITORS IN TREATMENT-NAIVE PATIENTS
Thomas Kuntzen;Joerg Timm;Andrew Berical;Niall Lennon.
In Vivo Distribution of the Human Immunodeficiency Virus/Simian Immunodeficiency Virus Coreceptors: CXCR4, CCR3, and CCR5
Linqi Zhang;Tian He;Andrew Talal;Gloria Wang.
Journal of Virology (1998)
Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C†
Marija Zeremski;Lydia M. Petrovic;Luis Chiriboga;Queenie B. Brown.
The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection
M. Zeremski;L. M. Petrovic;A. H. Talal.
Journal of Viral Hepatitis (2007)
The Effect of Commencing Combination Antiretroviral Therapy Soon after Human Immunodeficiency Virus Type 1 Infection on Viral Replication and Antiviral Immune Responses
Martin Markowitz;Mika Vesanen;Klara Tenner-Racz;Yunzhen Cao.
The Journal of Infectious Diseases (1999)
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
David Butera;Svetlana Marukian;Amy E. Iwamaye;Edgardo Hembrador.
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.
Randy S. Longman;Andrew H. Talal;Andrew H. Talal;Andrew H. Talal;Ira M. Jacobson;Ira M. Jacobson;Ira M. Jacobson;Matthew L. Albert;Matthew L. Albert;Matthew L. Albert.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: